Scholarlink

Purpose <p>This study examined the long-term effects of standard care lymphoedema treatment, delivered by cancer support centres in community-based settings, on quality of life and self-reported symptom severity among individuals with cancer-related lymphoedema (CRL).</p> Methods <p>A single-group pre-post pragmatic study design was adopted. Survivors of cancer referred to community-based cancer support centres were recruited. Participants received a minimum of 3 standard care lymphoedema treatment sessions at the centres with a certified lymphoedema clinician at baseline (T1), 1&#xa0;month (T2) and 6&#xa0;months (T3), where core treatment strategies included lymphoedema education to enable self-management, skin care and weight management. Assessments of quality of life and symptom severity were conducted at each visit using limb specific versions of the Lymphoedema Quality of Life (LYMQoL) questionnaire (i.e. arm LYMQoL, leg LYMQoL) as applicable for each person, and a researcher-developed tool of self-reported symptom severity.</p> Results <p>One-hundred and twenty survivors of cancer were recruited (mean age (± SD) 59 (± 12y); 90% female). Forty participants (33%) completed the T3 assessment. Linear mixed-model analyses demonstrated significant improvements in arm-CRL QoL (<i>n</i> = 78) and leg-CRL QoL (<i>n</i> = 18) from T1 to T3 (<i>p</i> &lt; 0.05), with small (Cohen’s <i>d</i> = 0.24) and large (Cohen’s <i>d</i> = 0.85) effect sizes respectively. All 7 self-reported symptom ratings, including pain, swelling and functional restriction, improved from T1–T3.</p> Conclusion <p>Standard care lymphoedema treatment, when delivered in community-based cancer support centres, was associated with improvements in QoL and self-reported symptoms among survivors of cancer with arm and leg lymphoedema at 6&#xa0;months.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A pragmatic evaluation of community-based lymphoedema services for individuals at risk of, or living with, cancer-related lymphoedema

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月28日

查看全文
  • Mairéad Cantwell,
  • Fiona Skelly,
  • Patricia Sheehan,
  • Michael O Brien,
  • Bróna Kehoe,
  • Niall Moyna,
  • Andrew McCarren,
  • Dorothy Thomas,
  • Bernie O’Loughlin,
  • Louise Mullen

摘要

Purpose

This study examined the long-term effects of standard care lymphoedema treatment, delivered by cancer support centres in community-based settings, on quality of life and self-reported symptom severity among individuals with cancer-related lymphoedema (CRL).

Methods

A single-group pre-post pragmatic study design was adopted. Survivors of cancer referred to community-based cancer support centres were recruited. Participants received a minimum of 3 standard care lymphoedema treatment sessions at the centres with a certified lymphoedema clinician at baseline (T1), 1 month (T2) and 6 months (T3), where core treatment strategies included lymphoedema education to enable self-management, skin care and weight management. Assessments of quality of life and symptom severity were conducted at each visit using limb specific versions of the Lymphoedema Quality of Life (LYMQoL) questionnaire (i.e. arm LYMQoL, leg LYMQoL) as applicable for each person, and a researcher-developed tool of self-reported symptom severity.

Results

One-hundred and twenty survivors of cancer were recruited (mean age (± SD) 59 (± 12y); 90% female). Forty participants (33%) completed the T3 assessment. Linear mixed-model analyses demonstrated significant improvements in arm-CRL QoL (n = 78) and leg-CRL QoL (n = 18) from T1 to T3 (p < 0.05), with small (Cohen’s d = 0.24) and large (Cohen’s d = 0.85) effect sizes respectively. All 7 self-reported symptom ratings, including pain, swelling and functional restriction, improved from T1–T3.

Conclusion

Standard care lymphoedema treatment, when delivered in community-based cancer support centres, was associated with improvements in QoL and self-reported symptoms among survivors of cancer with arm and leg lymphoedema at 6 months.